Bookmarks
Screening for a panel of gene variants associated with the risk for type 2 diabetes can identify adults at risk for the disorder but is not significantly better than assessment based on traditional risk factors such as weight, blood pressure and blood sugar levels.
Traditional risk factors, such as obesity, are just as useful, studies find.
Blood-group-factor family has a role in pH control.
Integrating motivational enhancement therapy with cognitive behavioral therapy may help people with type 1 diabetes better manage their disease, British researchers report.
Screening for a panel of gene variants associated with the risk for type 2 diabetes can identify adults at risk for the disorder but is not significantly better than assessment based on traditional risk factors such as weight, blood pressure and blood sugar levels. A multi-institutional research team, led by a Massachusetts General Hospital physician, reports their analysis of data from the ...
WEDNESDAY, Nov. 19 (HealthDay News) -- Testing for 18 different gene variations associated with type 2 diabetes was no better at predicting a person's risk for the blood sugar disease than a doctor's assessment, researchers report.
GI Dynamics, a medical device company pioneering the development of new approaches to treat obesity and type 2 diabetes, announced today a paper appearing in the advance online publication of the journal Obesity, which demonstrates that implantation of an innovative endoluminal sleeve mimics key, ben
WASHINGTON (Reuters) - Stem cells taken from the blood of a few diabetes patients have "re-set" their immune systems, helping 14 out of 15 live for months and even years without insulin, researchers reported on Tuesday.
Well, most people looks at diet pills as just another pill, now let me tell you that there is just those that are just pills and then there’s these diet pills that are really effective because of the thought that they have all the right ingredients to make our bodies make that possible change that we want.
Two popular leukemia drugs, Gleevec and Sutent, kept lab mice from developing type 1 diabetes and put 80 percent of diabetic mice in remission, an international team said on Monday.
© 2008 Blood Cord Bank